Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data

NCT07088718 ·Status: COMPLETED

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

NCT04847557 ·Status: COMPLETED ·Phase: PHASE3

Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity

NCT05912621 ·Status: RECRUITING ·Phase: PHASE2

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

NCT04916470 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

NCT06914895 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity

NCT06180616 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

NCT06662383 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure

NCT06423599 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

NCT06779929 ·Status: COMPLETED

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight

NCT04657003 ·Status: COMPLETED ·Phase: PHASE3

Semaglutide vs Dulaglutide on Epicardial Adipose Tissue

NCT04200625 ·Status: COMPLETED

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

NCT04660643 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)

NCT07247084 ·Status: RECRUITING ·Phase: PHASE4

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

NCT06962280 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity

NCT06373146 ·Status: COMPLETED ·Phase: PHASE2

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

NCT06606821 ·Status: RECRUITING ·Phase: PHASE4

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

NCT06803888 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes

NCT03861052 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

NCT06603571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

NCT04657016 ·Status: COMPLETED ·Phase: PHASE3

Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction

NCT06557811 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

NCT05556512 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

NCT04184622 ·Status: COMPLETED ·Phase: PHASE3

A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

NCT06047548 ·Status: COMPLETED ·Phase: PHASE3

Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction

NCT05371496 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2